(DAPT) in patients treated with Firehawk stents was non-inferior to 12 months of DAPT for the primary composite event of ...

Patients with a history of cocaine use who present with non-ST-segment elevation myocardial infarction have a lower risk of future major adverse cardiovascular events if treated invasively rather than ...

Lower risk for bleeding without increase in ischemic events seen for patients with acute coronary syndrome. HealthDay News — For patients with acute coronary syndrome (ACS) undergoing drug-eluting ...

Data from the EVOLVE Short DAPT study found that shortened three-month dual antiplatelet therapy (DAPT) did not increase myocardial infarction (MI) or stent thrombosis (ST) in high bleeding risk (HBR) ...

Whether the reduced ischemic risk from adding a novel oral anticoagulant (NOAC) to antiplatelets in patients with acute coronary syndromes (ACS) is worth the increased hazard from major bleeding may ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

A recent study sought to estimate the incidence of clinical events such as bleeding, myocardial infarction, and all-cause mortality in patients with acute myocardial infarction and chronic coronary ...

Further results from the MASTER DAPT trial of abbreviated dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) in patients at high bleeding risk stratified by use of oral ...

DENVER - November 1, 2017 - Elderly patients undergoing PCI often receive bare-metal stents (BMS) instead of drug-eluting stents (DES) to shorten the duration of dual antiplatelet therapy (DAPT) and ...

The 1-month dual antiplatelet (DAPT) strategy used in the STOPDAPT-2 acute coronary syndrome (ACS) trial failed to match the safety and efficacy outcomes of the original STOPDAPT-2 study. For a ...

Please provide your email address to receive an email when new articles are posted on . In a subgroup analysis of MASTER-DAPT, regardless of whether patients had a history of MI, 1-month DAPT after ...